07:12 AM EDT, 07/23/2024 (MT Newswires) -- Quest Diagnostics ( DGX ) reported Q2 adjusted diluted earnings Tuesday of $2.35 per share, up from $2.30 a year earlier.

Analysts polled by Capital IQ expected $2.33.

Revenue for the quarter ended June 30 was $2.40 billion, compared with $2.34 billion a year earlier.

Analysts surveyed by Capital IQ expected $2.39 billion.

The company raised its full-year 2024 adjusted diluted earnings forecast in a range of $8.80 to $9.00 per share from $8.72 to $8.97 per share previously. Analysts surveyed by Capital IQ expect $8.86. The company also increased its revenue outlook for the year to a range of $9.50 billion to $9.58 billion from $9.40 billion to $9.48 billion previously. Analysts polled by Capital IQ expect $9.45 billion.]

Price: 148.00, Change: +0.65, Percent Change: +0.44